US$ 24.32
triple action glp 1 Mechanisms of of GLP-1RA Targeting GLP-1, GIP & GCG
Description
Featuring 5 billion AFU akkermansia muciniphila and 10 billion CFU lactobacillus rhamnosus GG
President Trump recently announced a deal with drugmakers to expand access to GLP-1 drugs to Medicare patients starting in 2026

Trending GLP-1s (like Ozempic) are now raising red flags for nAMD.

Probiotics 2 billion CFU of targeted strains to help maintain gut health

Harness the power of nature for comprehensive metabolic support
